clinical trial
Phase I trial of Bangavax approved
The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.
Experimental Ebola vaccine safe, prompts immune response
An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses
July 17, 2022
Phase I trial of Bangavax approved
The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.
April 2, 2015
Experimental Ebola vaccine safe, prompts immune response
An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses
X